Targeting VEGF-A to Treat Cancer and Age-related Macular Degeneration

Overview

Journal Annu Rev Med

Publisher Annual Reviews

Specialty General Medicine

Date 2006 Oct 21

PMID 17052163

Citations 100

Authors

Napoleone Ferrara

Robert D Mass

Claudio Campa

Robert Kim

Affiliations

Soon will be listed here.

Abstract

Inhibiting angiogenesis is a promising strategy to treat cancer and several other disorders, including intraocular neovascular syndromes. The identification of vascular endothelial growth factor (VEGF)-A as a major regulator of normal and pathological angiogenesis has enabled significant progress toward effective treatments for such disorders. Several VEGF inhibitors have been recently approved by the U.S. Food and Drug Administration for the treatment of cancer and the neovascular form of age-related macular degeneration. This review summarizes the basic biology of VEGF-A and illustrates the clinical progress in targeting this molecule.

Citing Articles

Metal-based nanoparticle in cancer treatment: lessons learned and challenges.

Hheidari A, Mohammadi J, Ghodousi M, Mahmoodi M, Ebrahimi S, Pishbin E Front Bioeng Biotechnol. 2024; 12:1436297.

PMID: 39055339 PMC: 11269265. DOI: 10.3389/fbioe.2024.1436297.

The omega-3 postbiotic -10--15-octadecadienoic acid attenuates contact hypersensitivity in mice through downregulation of vascular endothelial growth factor A.

Saika A, Nagatake T, Kishino S, Kitamura N, Honda T, Hosomi K Front Cell Infect Microbiol. 2024; 14:1355679.

PMID: 38841110 PMC: 11151274. DOI: 10.3389/fcimb.2024.1355679.

Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update.

Rangaswamy D, Nagaraju S, Bhojaraja M, Swaminathan S, Prabhu R, Rao I Int Urol Nephrol. 2024; 56(8):2635-2644.

PMID: 38498275 PMC: 11266217. DOI: 10.1007/s11255-024-03990-1.

Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p/VEGFA and HuR/ZO-1 axes in esophageal squamous cell carcinoma.

Mao Y, Wang J, Wang Y, Fu Z, Dong L, Liu J Cell Death Discov. 2024; 10(1):133.

PMID: 38472174 PMC: 10933275. DOI: 10.1038/s41420-024-01905-8.

NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.

Sharma S, Ehrlich M, Zhang M, Blobe G, Henis Y Commun Biol. 2024; 7(1):112.

PMID: 38242992 PMC: 10799020. DOI: 10.1038/s42003-024-05798-2.